Headlines

BioNTech (22UA GY / BNTX) FY 2025 (EUR): Revenue 2.87bln (exp. 2.72bln), EPS -4.70 (exp. -3.08); outlook: Revenue 2-2.3bln (exp. 2.75bln)

Newsquawk Staff ·

BioNTech (22UA GY / BNTX) FY 2025 (EUR): Revenue 2.87bln (exp. 2.72bln), EPS -4.70 (exp. -3.08); outlook: Revenue 2-2.3bln (exp. 2.75bln)

What it means

BioNTech's FY 2025 earnings report shows a revenue beat against expectations, although its EPS fell short of estimates, indicating potential concerns about profitability. The forward guidance for revenue is notably lower than expected, which may dampen sentiment and put pressure on the stock as the market assesses the implications for growth going forward.

Related headlines